206 related articles for article (PubMed ID: 2876859)
1. Pharmacokinetics, metabolism, and disposition of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.
Gombar CT; Straub K; Levandoski P; Gutzait L; Swagzdis J; Garvie C; Joseph G; Potts BD; Mico BA
Drug Metab Dispos; 1986; 14(5):540-8. PubMed ID: 2876859
[TBL] [Abstract][Full Text] [Related]
2. Benzazepine metabolism revisited. Evidence for the formation of novel amine conjugates.
Straub K; Davis M; Hwang B
Drug Metab Dispos; 1988; 16(3):359-66. PubMed ID: 2900726
[TBL] [Abstract][Full Text] [Related]
3. Physiological disposition of CGS 16617 in rat, dog, and man.
Egger H; Kochak G; Robertson P; Iannucci R; Rufino FA; Stancato F
Drug Metab Dispos; 1989; 17(6):669-72. PubMed ID: 2575505
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog.
Tremaine LM; Welch WM; Ronfeld RA
Drug Metab Dispos; 1989; 17(5):542-50. PubMed ID: 2573498
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate of diltiazem. Distribution, excretion and protein binding in rat and dog.
Nakamura S; Suzuki T; Sugawara Y; Usuki S; Ito Y; Kume T; Yoshikawa M; Endo H; Ohashi M; Harigaya S
Arzneimittelforschung; 1987 Nov; 37(11):1244-52. PubMed ID: 3440032
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D
Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103
[TBL] [Abstract][Full Text] [Related]
12. Physiological disposition and metabolism of timolol in man and laboratory animals.
Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.
Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK
Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177
[TBL] [Abstract][Full Text] [Related]
15. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
[TBL] [Abstract][Full Text] [Related]
16. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of amezinium in rat and dog.
Traut M; Brode E; Neumann B; Kummer H
Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary clearance of vasoactive drugs: N-oxidation of SK&F 86466 in the isolated perfused rat lung.
Gombar CT; Burak E; Harper N; Smith BR
J Pharmacol Exp Ther; 1988 May; 245(2):402-6. PubMed ID: 2896791
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
Wahl D; Förster HJ; Pook KH; Richter I
Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
